Our Partners

RSS Investor Relations and News

  • MYOS RENS Technology to Present at the 9th Annual LD Micro Invitational in Los Angeles, CA May 21, 2019
    Company Presentation on Tuesday, June 4 at 3:40pm PT to Highlight its Core Nutritional Products CEDAR KNOLLS, N.J., May 21, 2019 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk [...]
    MYOS RENS Technology Reports 161% Increase in Revenues, 238% Increase in Gross Profit in First Quarter 2019 May 08, 2019
    Conference Call to be Held Tomorrow at 11am ET CEDAR KNOLLS, N.J., May 8, 2019 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition derive from fertilized egg yolk that helps build lean muscle in conjunction with [...]
    Learn More ›
  • 9th Annual LD Micro Invitational

    Luxe Sunset Boulevard Hotel in Los Angeles

    MYOS RENS Technology Q1 2019 Results Conference Call

    A digital replay of the Earnings Call available by telephone until August 30, 2019 and may be accessed by dialing 877-660-6853 from the U.S. or 201-612-7415 for international callers, using the Conference ID# 13690404.

    Digital Webcast replay available through May 23, 2019

Stock Snapshot

MYOS Symbol
NASDAQ Market
Market Cap
Price
Change
Volume